Bio Techne Correlations
TECH Stock | USD 75.36 0.02 0.03% |
The current 90-days correlation between Bio Techne Corp and Biomarin Pharmaceutical is 0.16 (i.e., Average diversification). The correlation of Bio Techne is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Bio Techne Correlation With Market
Weak diversification
The correlation between Bio Techne Corp and DJI is 0.32 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Bio Techne Corp and DJI in the same portfolio, assuming nothing else is changed.
Bio |
Moving together with Bio Stock
Moving against Bio Stock
0.32 | DRUG | Bright Minds Biosciences Trending | PairCorr |
0.53 | VTVT | vTv Therapeutics | PairCorr |
0.32 | ENGN | enGene Holdings Common | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Bio Stock performing well and Bio Techne Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Bio Techne's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
BMRN | 1.29 | (0.51) | 0.00 | (0.96) | 0.00 | 1.42 | 18.88 | |||
PCVX | 2.24 | 0.51 | 0.10 | (0.36) | 2.19 | 3.32 | 42.81 | |||
LQDA | 1.96 | 0.25 | 0.09 | 0.55 | 1.87 | 4.93 | 18.78 | |||
LEGN | 2.37 | (0.50) | 0.00 | (0.58) | 0.00 | 4.29 | 17.18 | |||
SGEN | 0.58 | (0.07) | 0.00 | (4.07) | 0.00 | 1.02 | 6.86 | |||
ALNY | 1.63 | (0.31) | 0.00 | (0.10) | 0.00 | 2.85 | 13.26 | |||
EXEL | 1.47 | 0.47 | 0.31 | 1.00 | 0.88 | 3.14 | 14.75 | |||
HALO | 2.38 | (0.58) | 0.00 | (0.24) | 0.00 | 3.90 | 28.41 | |||
REPL | 3.32 | 0.38 | 0.12 | 0.34 | 3.34 | 8.25 | 46.30 | |||
NUVL | 2.23 | 0.06 | 0.05 | 0.17 | 2.72 | 3.84 | 36.85 |
Bio Techne Corporate Management
Lynne Hohlfeld | Senior Division | Profile | |
Luca Cicchetti | Managing Director | Profile | |
Brenda JD | Gen VP | Profile | |
Martin Wirtz | Senior Development | Profile | |
Cheryl Bethune | Senior Officer | Profile |